305
Views
8
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Economic Evaluation for Ophthalmologists

, &
Pages 393-401 | Received 10 Jan 2006, Accepted 14 Apr 2006, Published online: 08 Jul 2009

REFERENCES

  • Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull WHO 2004; 82: 844–851, [INFOTRIEVE], [CSA]
  • Williams A. Health and Economics. Macmillan, Houndmills 1987
  • Drummond M F, O'Brien B, Stoddart G L, Torrance G W. Methods for the economic evaluation of health care programmes, 2nd ed. Oxford University Press, Oxford 1997
  • Frick K D, Foster A, Bah M, Faal H. Analysis of costs and benefits of the Gambian Eye Care Program. Arch Ophthalmol 2005; 123(2)239–243, [INFOTRIEVE], [CROSSREF], [CSA]
  • Gold M R, Siegel J E, Russell L B, Weinstein M C. Cost-effectiveness in health and medicine. Oxford University Press, New York 1996
  • Muralikrishnan R, Venkatesh R, Prajna N V, Frick K D. Economic cost of cataract surgery procedures in an established eye care centre in Southern India. Ophthalmic Epidemiol 2004; 11(5)369–380, [INFOTRIEVE], [CROSSREF], [CSA]
  • Jampel H D, Schwartz G F, Robin A L, et al. Patient preferences for eye drop characteristics: a willingness-to-pay analysis. Arch Ophthalmol 2003; 121(4)540–546, [INFOTRIEVE], [CROSSREF], [CSA]
  • Brown M. Utility analysis tells all. Br J Ophthalmol 2005; 89(10)1233, [INFOTRIEVE], [CROSSREF], [CSA]
  • Gupta S K, Viswanath K, Thulasiraj R D, et al. The development of the Indian Vision Function Questionnaire (IND-VFQ): field testing and psychometric evaluation. Br J Ophthalmol 2005; 89(10)621–627, [INFOTRIEVE], [CROSSREF], [CSA]
  • 2006, EQ-5D E. http://www.euroqol.org/web/
  • Brown G C. Vision and quality-of-life. Trans Am Ophthalmol Soc 1999; 97: 473–511, [INFOTRIEVE], [CSA]
  • Torrance G W, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care 1989; 5(4)559–575, [INFOTRIEVE], [CSA]
  • Cairns J. Discounting in economic evaluation. Economic evaluation in health care ed, M Drummond, A McGuire. Oxford University Press, Oxford 2001; 236–255
  • Rouland J F, Le Pen C, Gouveia Pinto C, Berto P, Berdeaux G. Cost-minimisation study of dorzolamide versus brinzolamide in the treatment of ocular hypertension and primary open-angle glaucoma: in four European countries. Pharmacoeconomics 2003; 21(3)201–213, [INFOTRIEVE], [CROSSREF], [CSA]
  • Florio M. The economic rate of return of infrastructures and regional policy in the European Union. Ann Public Coop Econ 1997; 68(1)39–64, [CROSSREF], [CSA]
  • Black W C. The CE plane: a graphic representation of cost-effectiveness. Med Decis Making 1990; 10(3)212–214, [INFOTRIEVE], [CSA]
  • James M, Turner D A, Broadbent D M, Vora J, Harding S P. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. Br Med J 2000; 320(7250)1627–1631, [CROSSREF], [CSA]
  • Laupacis A, Feeny D, Detsky A S, Tugwell P X. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. Can Med Assoc J 1992; 146(4)473–481, [CSA]
  • Ubel P A, Hirth R A, Chernew M E, Fendrick A M. What is the price of life and why doesn't it increase at the rate of inflation?. Arch Intern Med 2003; 163(14)1637–1641, [INFOTRIEVE], [CROSSREF], [CSA]
  • Busbee B G, Brown G C, Brown M M. Cost-effectiveness of ocular interventions. Curr Opin Ophthalmol 2003; 14(3)132–138, [INFOTRIEVE], [CROSSREF], [CSA]
  • Kuntz K, Weinstein M. Modelling in economic evaluation. Economic evaluation in health care ed, M Drummond, A McGuire. Oxford University Press, Oxford 2001; 141–171
  • Lairson D R, Begley C E, Reynolds T F, Wilhelmus K R. Prevention of herpes simplex virus eye disease: a cost-effectiveness analysis. Arch Ophthalmol 2003; 121: 108–112, [INFOTRIEVE], [CSA]
  • Sonnenberg F A, Beck J R. Markov models in medical decision making: a practical guide. Med Decis Making 1993; 13(4)322–338, [INFOTRIEVE], [CSA]
  • Smith D H, Fenn P, Drummond M. Cost effectiveness of photodynamic therapy with verteporfin for age-related macular degeneration: the UK case. Br J Ophthalmol 2004; 88(9)1107–1112, [INFOTRIEVE], [CROSSREF], [CSA]
  • Briggs A. Handling uncertainty in economic evaluation and presenting the results. Economic evaluation in health care ed, M Drummond, A McGuire. Oxford University Press, Oxford 2001; 172–214
  • Marseille E. Cost-effectiveness of cataract surgery in a public health eye care programme in Nepal. Bull WHO 1996; 74(3)319–324, [INFOTRIEVE], [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.